Cart
sales@molnova.com
Home - Products - Others - Other Targets - (2S)-6-methylhept-5-en-2-ol

(2S)-6-methylhept-5-en-2-ol

CAS No. 58917-26-3

(2S)-6-methylhept-5-en-2-ol( —— )

Catalog No. M37376 CAS No. 58917-26-3

(2S)-6-methylhept-5-en-2-ol ((S)-(+)-6-Methyl-5-Hepten-2-OL) is a pheromone component of Cerambycid beetles in the Lamiinae subfamily.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 53 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    (2S)-6-methylhept-5-en-2-ol
  • Note
    Research use only, not for human use.
  • Brief Description
    (2S)-6-methylhept-5-en-2-ol ((S)-(+)-6-Methyl-5-Hepten-2-OL) is a pheromone component of Cerambycid beetles in the Lamiinae subfamily.
  • Description
    (2S)-6-methylhept-5-en-2-ol ((S)-(+)-6-Methyl-5-Hepten-2-OL) is a pheromone component of Cerambycid beetles in the Lamiinae subfamily. The S configuration of 6-methylhept-5-en-2-o is inactive, and only the mixture of S and R configurations is active.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58917-26-3
  • Formula Weight
    128.21
  • Molecular Formula
    C8H16O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](O)CCC=C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Sapecin

    Sapecin

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • Boc-(Lys9)-Neurotens...

    Boc-(Lys9)-Neurotensin (9-13)-methyl ester

Sign In Join Free